WALTHAM, Mass., Millennium Research Group (MRG) has conducted a detailed analysis of the US aesthetics lasers market in its US Markets for Aesthetics Lasers and Energy Devices 2007 report. The analysis reveals that over the next five years more women will be receiving cellulite reduction procedures as noninvasive cellulite reduction products receive over- the-counter FDA approvals. In 2006, 330,000 people in the US received laser and energy device assisted cellulite reduction procedures, and by 2011 that number will more than double.
While most aesthetic laser procedures require some level of physician supervision or intervention, a number of noninvasive cellulite reduction devices will gain over the counter approval by the FDA. Over the counter cellulite reduction devices will be readily adopted in spas because they garner significantly higher overall profit margins versus most spa based procedures.
"Although cellulite occurs in individuals of varying weights, cellulite severity is correlated with increased weight. In the US, the average weight is increasing annually, particularly in younger generations, thereby expanding the population pool for cellulite reduction treatment," says Jaya Classen, senior analyst at MRG. "The expanding patient pool combined with increasing awareness and acceptance of medical cellulite reduction procedures, will drive growth in this market through 2011 and beyond."
The US Markets for Aesthetics Lasers and Energy Devices 2007 report includes coverage of key industry competitors, including Candela Corporation, Lumenis, Palomar Medical Technologies, Cutera, Alma Lasers, Syneron, and Reliant.